Our prior studies established and characterized a metastatic PCa genetically engineered mouse (GEM) model with PB-Cre-driven co-deletion of Pten/Smad4/Trp53 (PbPPS)26,27. The gene discussed is PTEN; the disease is posterior cortical atrophy.